glp 1 medication retatrutide Triple Agonist (GLP-1/GIP/GCG) Retatrutide Promises Big Weight Loss,

*Correspondence: Yanling Huang, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

These often occur during the initial weeks of treatment but usually, improve over time as your body adjusts to the medication

Retrieved 14 May 2022, from A Phase II, Randomised Pilot Study to Evaluate the Efficacy and Safety of Subcutaneous, Bioresorbable Afamelanotide Implants and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegm

Diaz-Jimenez, D., Petrillo, M